Merck, primarily known as a science and technology company, is involved in the space industry through research and development activities. They leverage the microgravity environment of the International Space Station (ISS) to conduct experiments, particularly in protein crystallization, with the goal of improving drug delivery and manufacturing processes. Merck partners with organizations like NASA and ESA to advance aerospace technology and explore in-space manufacturing for pharmaceutical applications, specifically targeting enhanced and simpler drug delivery, with potential benefits for drugs like Keytruda.
All verified mentions of this organization in source documents.
Alcan Systems received a collective 7,500,000 EUR investment last year from SES, the Merck Group, and the Beijing Singularity Power Investment Fund.